Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03OKS
|
|||
| Former ID |
DNCL002264
|
|||
| Drug Name |
DC-IL-12 DNA therapeutic
|
|||
| Synonyms |
INXN-3001
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1 | [1] | |
| Company |
ZIOPHARM Oncology
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00815607) Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.